Skip to main content
HighlightsHighlights Archive

Media Monitoring: 26th March – 1st April

By April 1, 2022No Comments

Brand new Ascot hospital unveiled to tackle NHS backlog

  • Heatherwood Hospital, part of Frimley Health NHS Foundation Trust, will give priority to those patients waiting the longest, especially for orthopaedic and ophthalmology services
  • The hospital boasts six operating theatres, 48 inpatient beds and 22 day-case cubicles and will give patients in Berkshire, Surrey and Hampshire access to state-of-the-art diagnostic, surgical and outpatient care
  • Its unveiling was welcomed by Sajid Javid, Secretary of State for Health and Social Care, and NHS Chief Executive, Amanda Pritchard

https://www.england.nhs.uk/2022/03/new-state-of-the-art-nhs-hospital-to-help-tackle-covid-backlog/

 

UK experts fear and end to community COVID testing will put vulnerable people at risk

  • In spite of soaring cases, COVID levels are expected to decline due to a lack of testing caused by the Government’s decision to end free testing across England, with devolved nations set to follow soon
  • Experts feat that a lack of community testing will impact our ability to monitor vaccine effectiveness and the severity of current COVID strains
  • From April 1st, only a few groups will have access to free tests if symptomatic, including healthcare staff and hospital patients

https://www.theguardian.com/world/2022/mar/28/end-of-free-covid-testing-could-put-vulnerable-at-risk-say-uk-experts

 

Government update: Research and innovation sanctions on Russia and support for Ukraine

  • George Freeman MP, Minister for Science, Research & Innovation, announces UK government response with £3 million package to support Ukrainian researchers at risk
  • All payments for projects delivered through UK public research funds with a Russian dimension have been paused
  • The Government have suspended existing government to government dialogue through our science and innovation network team in Russia including their collaborative science projects

https://www.gov.uk/government/news/research-and-innovation-sanctions-on-russia-and-support-for-ukraine

 

Test for head and neck cancer patients can determine best treatment pathway

  • Research has shown that testing based on the levels of a key immune protein (PD-L1) can determine whether immunotherapy, chemotherapy or both is most effective for those with head or neck cancer
  • It is hoped that the test is implemented into guidelines to ensure that patients receive more personalised, effective care

https://www.icr.ac.uk/news-archive/test-can-personalise-use-of-immunotherapy-and-chemotherapy-for-head-and-neck-cancer

 

NIHR publishes latest annual report for 2020/21

  • The NIHR has published its latest annual report highlighting its milestones and achievements during 2020/21
  • The report celebrates NIHR’s response to COVID as well as highlighting their continued investment in groundbreaking research
  • NIHR rapidly funded research into COVID-19 and trials , to the tune of £108 million, to ensure world-class scientists across the UK and lower and middle income countries could tackle the virus in a multitude of ways, including discovering effective COVID treatments

https://www.nihr.ac.uk/news/nihr-publishes-latest-annual-report/30243

 

Government report: Clinically-led review of NHS cancer standards – models of care and measurement

  • The Government have released a report examining ways in which to improve cancer waiting times and patient outcomes
  • Members will be particularly interested in their focus on diagnosis (page 11) and testing (pages 14-15) pages
  • More patients should go ‘straight to test’ without wasting time seeing a clinician in order to satisfy outdated 2 week wait standards
  • The 2 week wait will be replaced in 2022, instead focusing on diagnosing or ruling out cancer as quickly as possible through testing

https://www.england.nhs.uk/publication/clinically-led-review-of-nhs-cancer-standards-models-of-care-and-measurement/

 

Study urges UK and US to take more action to solve global cancer epidemic

  • The study shows that, while cooperation between the US and the UK has increased over the past 40 years, key gaps have been identified
  • Research, while effective, has been far too narrow in scope – often neglecting important domains including screening, surgery, radiotherapy, health services research (including implementation science), palliative care, and survivorship
  • Researchers state that focusing on a broader agenda involving increased data intelligence will yield better results globally and show decisive international leadership on the issue

https://www.kcl.ac.uk/news/urgent-action-required-for-the-uk-and-us-to-tackle-the-global-cancer-epidemic

 

Scientists develop revolutionary synthetic antibiotics which can kill superbugs

  • University of Liverpool scientists have discovered a new class of synthetic antibiotics which can kill superbugs, including MRSA, without detectable resistance
  • This key discovery could revolutionise the way in which bacterial infections are treated
  • The synthetic teixobactin molecule, which has been developed in versions to optimise safety and efficacy, can also be produced inexpensively at scale – potentially saving millions of lives

https://www.healtheuropa.eu/scientists-develop-synthetic-antibiotics-to-tackle-drug-resistant-superbugs/114480/

 

£500 million Canary Wharf project to build Europe’s biggest commercial lab

  • Dutch company Kadans Science Partner, lab-building specialists and the Canary Wharf Group have announced a deal to build a new 22-storey building that will have 750,000 square feet of space devoted to labs
  • The £500 million building will be filled with a mixture of biotech startups, academics, clinicians, and more established pharmaceutical companies and provide thousands of jobs
  • The block, to be completed in 2026, will be the largest commercial lab space in Europe and form the cornerstone of a new 3.3 hectare development on the Wharf’s North Quay meant to attract life sciences businesses spanning biotech to healthcare

https://www.standard.co.uk/business/canary-wharf-kadans-science-partner-lab-development-life-sciences-biotech-pharma-b991372.html

 

Lifechanging technology to be rolled out to all type 1 diabetes patients

  • Everyone living with type 1 diabetes will be eligible for lifechanging flash glucose monitors on the NHS, thanks to new guidance published today
  • The wearable gadgets, the size of a £2 coin, have a sensor that easily sits on the arm, allowing patients to check their glucose levels with a one-second scan
  • New research presented this week at the Diabetes UK Professional Conference 2022 revealed that flash monitoring not only helps to improve blood glucose levels in people with type 1 diabetes, but also has a positive effect on their quality of life

https://www.england.nhs.uk/2022/03/lifechanging-technology-to-be-rolled-out-to-all-type-1-diabetes-patients/

 

Ben Kemp

About Ben Kemp